Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PRTA

Prothena (PRTA)

Prothena Corporation PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTA
DateTimeSourceHeadlineSymbolCompany
01/03/20256:45PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:PRTAProthena Corporation PLC
12/30/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
12/30/20243:05PMBusiness WireProthena Announces Board of Directors UpdateNASDAQ:PRTAProthena Corporation PLC
12/19/202412:05AMBusiness WireRoche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s DiseaseNASDAQ:PRTAProthena Corporation PLC
11/13/20246:00AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PRTAProthena Corporation PLC
11/12/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
11/12/20243:05PMBusiness WireProthena Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
11/05/20243:05PMBusiness WireProthena to Report Third Quarter 2024 Financial Results on November 12NASDAQ:PRTAProthena Corporation PLC
10/03/20245:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
10/03/20245:57PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
09/27/20243:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
09/27/20243:05PMBusiness WireProthena Announces Leadership Team UpdatesNASDAQ:PRTAProthena Corporation PLC
08/29/20243:05PMBusiness WireProthena to Participate in Upcoming Healthcare ConferencesNASDAQ:PRTAProthena Corporation PLC
08/08/20244:13PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRTAProthena Corporation PLC
08/08/20243:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRTAProthena Corporation PLC
08/08/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
08/08/20243:05PMBusiness WireProthena Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
08/01/20243:05PMBusiness WireProthena to Report Second Quarter 2024 Financial Results on August 8NASDAQ:PRTAProthena Corporation PLC
05/28/20243:05PMBusiness WireProthena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development CollaborationNASDAQ:PRTAProthena Corporation PLC
05/17/20243:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
05/17/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
05/17/20243:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
05/17/20243:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
05/08/20243:19PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRTAProthena Corporation PLC
05/08/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
05/08/20243:05PMBusiness WireProthena Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
05/01/20243:05PMBusiness WireProthena to Report First Quarter 2024 Financial Results on May 8NASDAQ:PRTAProthena Corporation PLC
04/15/20243:05PMBusiness WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & LymphomaNASDAQ:PRTAProthena Corporation PLC
03/05/20248:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
03/05/20248:01PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
 Showing the most relevant articles for your search:NASDAQ:PRTA